Bristol-Myers Squibb (BMY) Receives FTC Second Request in Connection with Celgene (CELG) Deal

March 26, 2019 7:10 AM
Bristol-Myers Squibb (NYSE: BMY) disclosed in an SEC filing related to is deal with Celgene (NASDAQ: CELG):

As ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Mergers and Acquisitions

Next Articles